Please assess the completion status of the following clinical trial:

Trial Title: Changing Agendas on Sleep, Treatment and Learning in Epilepsy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 6.0

Eligibility Criteria:
Inclusion Criteria:~1. Children diagnosed with RE (see International League Against Epilepsy Diagnostic Manual at https://www.epilepsydiagnosis.org/syndrome/ects-overview.html)~2. EEG showing focal sharp waves with normal background (see International League Against Epilepsy Diagnostic Manual at https://www.epilepsydiagnosis.org/syndrome/ects-eeg.html)~3. Aged ≥5 years and \<13 years at the time of randomisation~4. Currently untreated with antiepileptic drugs~5. Written informed consent received from person with parental responsibility/legal representative.~6. Family have an email address and regular internet access (for online sleep intervention)~7. Parent and child are to have a good understanding of the English language~Exclusion Criteria:~1. Known contraindication to any of the trial drugs~2. Previously treated for epilepsy with antiepileptic drugs

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 12 Years
- Healthy Volunteers: f

Study Arms:
- Carbamazepine plus sleep intervention (Type: ACTIVE_COMPARATOR): None
- Carbamazepine plus standard care (Type: ACTIVE_COMPARATOR): None
- Levetiracetam plus sleep intervention (Type: ACTIVE_COMPARATOR): None
- Levetiracetam plus standard care (Type: ACTIVE_COMPARATOR): None
- No AED plus sleep intervention (Type: ACTIVE_COMPARATOR): None
- No AED plus standard care (Type: NO_INTERVENTION): None

Based on this trial design, predict the completion outcome and termination type (if applicable).